In this Review, we try to provide translational researchers with a simplified but accurate understanding of how energy homeostasis is regulated at the transcriptional level. We introduce the many components involved in manipulating transcription and explain how they are involved in the regulation of energy homeostasis.
We discuss the key intracellular and extracellular ligand-dependent and cell membrane receptor-dependent transcription factors involved in energy homeostasis and their transcriptional co-regulators.
We summarize what are likely to be causal links of transcription factor mutations and human disease.
We discuss in brief the new emerging field of intergenerational transcriptional control of metabolism.
Crosstalk between multiple signalling cascades and transcription factors and co-regulators, in the form of post-transcriptional modifications, provides the key mode of their integration into the cellular context.
With our increasing understanding of how chromatin provides an interface between transcription factors, co-regulators and the DNA blueprint, we have witnessed a dramatic change in our understanding of the complexity of gene regulation. We outline how various metabolites influence the establishment and removal of chromatin marks.
We provide insights into how emerging concepts such as non-coding RNAs, genome accessibility and chromosome conformation transform the field of transcriptional control of energy homeostasis.
Obesity and its associated diseases are expected to affect more than 1 billion people by the year 2030. These figures have sparked intensive research into the molecular control of food intake, nutrient distribution, storage and metabolism — processes that are collectively termed energy homeostasis. Recent decades have also seen dramatic developments in our understanding of gene regulation at the signalling, chromatin and post-transcriptional levels. The seemingly exponential growth in this complexity now poses a major challenge for translational researchers in need of simplified but accurate paradigms for clinical use. In this Review, we consider the current understanding of transcriptional control of energy homeostasis, including both transcriptional and epigenetic regulators, and crosstalk between pathways. We also provide insights into emerging developments and challenges in this field.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
High-fat diet in early life triggers both reversible and persistent epigenetic changes in the medaka fish (Oryzias latipes)
BMC Genomics Open Access 21 August 2023
Chemokine C–C motif ligand 2 overexpression drives tissue-specific metabolic responses in the liver and muscle of mice
Scientific Reports Open Access 20 July 2020
Nature Communications Open Access 31 January 2020
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Brivanlou, A. H. & Darnell, J. E. Signal transduction and the control of gene expression. Science 295, 813–818 (2002).
Mullican, S. E., DiSpirito, J. R. & Lazar, M. A. The orphan nuclear receptors at their 25-year reunion. J. Mol. Endocrinol. 51, T115–T140 (2013).
Evans, R. M. & Mangelsdorf, D. J. Nuclear receptors, RXR, and the Big Bang. Cell 157, 255–266 (2014). Its capacity to form dimers with multiple nuclear receptors puts RXR at the centre of molecular endocrinology. This review provides a comprehensive overview of nuclear receptors and in particular of how RXR influences their activity in a physiological context.
Nakahata, Y. et al. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134, 329–340 (2008).
IJpenberg, A. et al. In vivo activation of PPAR target genes by RXR homodimers. EMBO J. 23, 2083–2091 (2004).
Fan, W. & Evans, R. PPARs and ERRs: molecular mediators of mitochondrial metabolism. Curr. Opin. Cell Biol. 33, 49–54 (2015).
Calkin, A. C. & Tontonoz, P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat. Rev. Mol. Cell Biol. 13, 213–224 (2012).
Jiang, G., Nepomuceno, L., Hopkins, K. & Sladek, F. M. Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol. Cell. Biol. 15, 5131–5143 (1995).
Yuan, X. et al. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS ONE 4, e5609 (2009).
Martinez-Jimenez, C. P., Kyrmizi, I., Cardot, P., Gonzalez, F. J. & Talianidis, I. Hepatocyte nuclear factor 4α coordinates a transcription factor network regulating hepatic fatty acid metabolism. Mol. Cell. Biol. 30, 565–577 (2010).
Zaret, K. S. & Carroll, J. S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25, 2227–2241 (2011).
Nakae, J., Kitamura, T. Silver, D. L. & Accili, D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108, 1359–1367 (2001).
Altarejos, J. Y. & Montminy, M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol. 12, 141–151 (2011).
Oh, K.-J., Han, H.-S., Kim, M.-J. & Koo, S.-H. CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis. BMB Rep. 46, 567–574 (2013).
Bernardo, A. S., Hay, C. W. & Docherty, K. Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic β cell. Mol. Cell. Endocrinol. 294, 1–9 (2008).
Kim, M.-S. et al. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat. Neurosci. 9, 901–906 (2006).
Kitamura, T. et al. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat. Med. 12, 534–540 (2006).
Münzberg, H., Huo, L., Nillni, E. A., Hollenberg, A. N. & Bjørbæk, C. Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology 144, 2121–2131 (2003).
Gao, Q. et al. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc. Natl Acad. Sci. USA 101, 4661–4666 (2004).
Gong, L. et al. Signal transducer and activator of transcription-3 is required in hypothalamic agouti-related protein/neuropeptide Y neurons for normal energy homeostasis. Endocrinology 149, 3346–3354 (2008).
Xu, A. W., Ste-Marie, L., Kaelin, C. B. & Barsh, G. S. Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased Pomc expression, mild obesity, and defects in compensatory refeeding. Endocrinology 148, 72–80 (2007).
Lee, J.-Y. et al. Loss of cytokine-STAT5 signaling in the CNS and pituitary gland alters energy balance and leads to obesity. PLoS ONE 3, e1639 (2008).
Fain, J. N., Ihle, J. H. & Bahouth, S. W. Stimulation of lipolysis but not of leptin release by growth hormone is abolished in adipose tissue from Stat5a and b knockout mice. Biochem. Biophys. Res. Commun. 263, 201–205 (1999).
Richard, A. J. & Stephens, J. M. The role of JAK–STAT signaling in adipose tissue function. Biochim. Biophys. Acta 1842, 431–439 (2014).
Havula, E. & Hietakangas, V. Glucose sensing by ChREBP/MondoA–Mlx transcription factors. Semin. Cell Dev. Biol. 23, 640–647 (2012).
Filhoulaud, G., Guilmeau, S., Dentin, R., Girard, J. & Postic, C. Novel insights into ChREBP regulation and function. Trends Endocrinol. Metab. 24, 257–268 (2013).
Düvel, K. et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171–183 (2010).
Albert, V. & Hall, M. N. mTOR signaling in cellular and organismal energetics. Curr. Opin. Cell Biol. 33, 55–66 (2015).
Bugge, A. & Mandrup, S. Molecular mechanisms and genome-wide aspects of PPAR subtype specific transactivation. PPAR Res. 2010,169506 (2010).
Puigserver, P. et al. Activation PPARγ coactivator-1 through transcription factor dock. Science 286, 1368–1371 (1999).
Rodgers, J. T. et al. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434, 113–118 (2005).
Puigserver, P. Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-α. Int. J. Obes. (Lond.) 29, S5–S9 (2005).
Li, P. et al. Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity. Cell 147, 815–826 (2011).
Chung, H. T. RIP140, a Janus metabolic switch involved in defense functions. Cell. Mol. Immunol. 10, 7–9 (2013).
Jia, Y. et al. Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARα-regulated gene expression in liver. J. Biol. Chem. 279, 24427–24434 (2004).
Chen, W., Zhang, X., Birsoy, K. & Roeder, R. G. A muscle-specific knockout implicates nuclear receptor coactivator MED1 in the regulation of glucose and energy metabolism. Proc. Natl Acad. Sci. USA 107, 10196–10201 (2010).
Spencer, T. E. et al. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389, 194–198 (1997).
Chen, H. et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569–580 (1997).
Dasgupta, S., Lonard, D. M. & O'Malley, B. W. Nuclear receptor coactivators: master regulators of human health and disease. Annu. Rev. Med. 65, 279–292 (2014). There is no comprehensive review on the myriad transcriptional co-regulators. However, this review provides insight into the biology of NCoAs of the SRC family. The authors also outline the involvement of these co-activators in normal physiology and their dysregulation in disease.
Jenuwein, T. & Allis, C. D. Translating the histone code. Science 293, 1074–1080 (2001).
Phillips, D. M. The presence of acetyl groups of histones. Biochem. J. 87, 258–263 (1963).
Allfrey, V. G. Structural modifications of histones and their possible role in the regulation of ribonucleic acid synthesis. Proc. Can. Cancer Conf. 6, 313–335 (1966).
Takahashi, H., McCaffery, J. M., Irizarry, R. A. & Boeke, J. D. Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol. Cell 23, 207–217 (2006).
Wellen, K. E. et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076–1080 (2009).
Sutendra, G. et al. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell 158, 84–97 (2014).
Jin, Q. et al. Distinct roles of GCN5/PCAF-mediated H3K9ac CBP/p300-mediated H3K18/27ac nuclear receptor transactivation. EMBO J. 30, 249–262 (2011).
Imai, S. et al. Sir2: an NAD-dependent histone deacetylase that connects chromatin silencing, metabolism, and aging. Cold Spring Harb. Symp. Quant. Biol. 65, 297–302 (2000).
Sassone-Corsi, P. NAD+, a circadian metabolite with an epigenetic twist. Endocrinology 153, 1–5 (2012).
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M. & Sassone-Corsi, P. Circadian control of the NAD+ salvage pathway by CLOCK–SIRT1. Science 324, 654–657 (2009).
Murayama, A. et al. Epigenetic control of rDNA loci in response to intracellular energy status. Cell 133, 627–639 (2008).
Mostoslavsky, R. et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315–329 (2006).
Zhong, L. et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1α. Cell 140, 280–293 (2010).
Feldman, J. L., Baeza, J. & Denu, J. M. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J. Biol. Chem. 288, 31350–31356 (2013).
Shimazu, T. et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339, 211–214 (2013).
Donohoe, D. R. et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48, 612–626 (2012).
Shyh-Chang, N. et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 339, 222–226 (2013).
Sadhu, M. J. et al. Nutritional control of epigenetic processes in yeast and human cells. Genetics 195, 831–844 (2013).
Shi, Y. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941–953 (2004).
Tsukada, Y.-I. et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811–816 (2006).
Forneris, F., Binda, C., Vanoni, M. A., Mattevi, A. & Battaglioli, E. Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process. FEBS Lett. 579, 2203–2207 (2005).
Hino, S. et al. FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure. Nat. Commun. 3, 758 (2012).
Cervera, A. M., Bayley, J.-P., Devilee, P. & McCreath, K. J. Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Mol. Cancer 8, 89 (2009).
Xiao, M. et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326–1338 (2012).
Sakabe, K., Wang, Z. & Hart, G. W. β-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc. Natl Acad. Sci. USA 107, 19915–19920 (2010).
Zhang, S., Roche, K., Nasheuer, H.-P. & Lowndes, N. F. Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated. J. Biol. Chem. 286, 37483–37495 (2011).
Xu, Q. et al. AMPK regulates histone H2B O-GlcNAcylation. Nucleic Acids Res. 42, 5594–5604 (2014).
Hanover, J. A., Krause, M. W. & Love, D. C. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell Biol. 13, 312–321 (2012).
Bungard, D. et al. Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science 329, 1201–1205 (2010).
Rossetto, D., Avvakumov, N. & Côté, J. Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics 7, 1098–1108 (2012).
Jump, D. B., Butt, T. R. & Smulson, M. Nuclear protein modification and chromatin substructure. 3. Relationship between poly(adenosine diphosphate) ribosylation and different functional forms of chromatin. Biochemistry 18, 983–990 (1979).
Bai, P. et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13, 461–468 (2011).
Erener, S. et al. ARTD1 deletion causes increased hepatic lipid accumulation in mice fed a high-fat diet and impairs adipocyte function and differentiation. FASEB J. 26, 2631–2638 (2012).
Erener, S. et al. Poly(ADP-ribose)polymerase-1 (PARP1) controls adipogenic gene expression and adipocyte function. Mol. Endocrinol. 26, 79–86 (2012).
Xie, Z. et al. Lysine succinylation and lysine malonylation in histones. Mol. Cell Proteomics 11, 100–107 (2012).
Chen, Y. et al. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell Proteomics 6, 812–819 (2007).
García- Giménez, J. L. et al. Histone H3 glutathionylation in proliferating mammalian cells destabilizes nucleosomal structure. Antioxid. Redox Signal. 19, 1305–1320 (2013).
Posavec, M., Timinszky, G. & Buschbeck, M. Macro domains as metabolite sensors on chromatin. Cell. Mol. Life Sci. 70, 1509–1524 (2013).
Boulard, M. et al. Histone variant macroH2A1 deletion in mice causes female-specific steatosis. Epigenetics Chromatin 3, 8 (2010).
Changolkar, L. N. et al. Developmental changes in histone macroH2A1-mediated gene regulation. Mol. Cell. Biol. 27, 2758–2764 (2007).
Pehrson, J. R., Changolkar, L. N., Costanzi, C. & Leu, N. A. Mice without macroH2A histone variants. Mol. Cell. Biol. 34, 4523–4533 (2014).
Bocker, M. T. et al. Hydroxylation of 5-methylcytosine by TET2 maintains the active state of the mammalian HOXA cluster. Nat. Commun. 3, 818 (2012).
Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930–935 (2009).
Nitert, M. D. et al. Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes 61, 3322–3332 (2012).
Barres, R. et al. Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep. 3, 1020–1027 (2013).
Berrabah, W., Aumercier, P., Lefebvre, P. & Staels, B. Control of nuclear receptor activities in metabolism by post-translational modifications. FEBS Lett. 585, 1640–1650 (2011).
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G. & Cohen, P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem. 274, 17179–17183 (1999).
Yamagata, K. et al. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol. Cell 32, 221–231 (2008).
Housley, M. P. et al. O-GlcNAc regulates FoxO activation in response to glucose. J. Biol. Chem. 283, 16283–16292 (2008).
Rechavi, O. et al. Starvation-induced transgenerational inheritance of small RNAs in C. elegans. Cell 158, 277–287 (2014).
Gapp, K. et al. Implication of sperm RNAs in transgenerational inheritance of the effects of early trauma in mice. Nat. Neurosci. 17, 667–669 (2014).
Radford, E. J. et al. In utero undernourishment perturbs the adult sperm methylome and intergenerational metabolism. Science 345, 1255903 (2014).
Padmanabhan, N. et al. Mutation in folate metabolism causes epigenetic instability and transgenerational effects on development. Cell 155, 81–93 (2013).
Carone, B. R. et al. Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals. Cell 143, 1084–1096 (2010).
Öst, A. et al. Paternal diet defines offspring chromatin state and intergenerational obesity. Cell 159, 1352–1364 (2014).
Dekker, J., Marti-Renom, M. A. & Mirny, L. A. Exploring the three-dimensional organization of genomes: interpreting chromatin interaction data. Nat. Rev. Genet. 14, 390–403 (2013).
Xu, Z., Lefevre, G. M. & Felsenfeld, G. Chromatin structure, epigenetic mechanisms and long-range interactions in the human insulin locus. Diabetes Obes. Metab. 14, S1–S11 (2012).
Ostuni, R. et al. Latent enhancers activated by stimulation in differentiated cells. Cell 152, 157–171 (2013).
Holoch, D. & Moazed, D. RNA-mediated epigenetic regulation of gene expression. Nat. Rev. Genet. 16, 71–84 (2015). Non-coding RNAs are involved in genome regulation. This review gives a detailed overview of different classes of small and long non-coding RNAs and how they are mechanistically involved in transcriptional regulation.
Herzog, V. A. et al. A strand-specific switch in noncoding transcription switches the function of a Polycomb/Trithorax response element. Nat. Genet. 46, 973–981 (2014).
Ross, S. A. & Davis, C. D. The emerging role of microRNAs and nutrition in modulating health and disease. Annu. Rev. Nutr. 34, 305–336 (2014).
Huang, X. A. et al. A major epigenetic programming mechanism guided by piRNAs. Dev. Cell 24, 502–516 (2013).
Le Thomas, A. et al. Piwi induces piRNA-guided transcriptional silencing and establishment of a repressive chromatin state. Genes Dev. 27, 390–399 (2013).
Brennecke, J. et al. Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell 128, 1089–1103 (2007).
Watanabe, T. et al. MITOPLD is a mitochondrial protein essential for nuage formation and piRNA biogenesis in the mouse germline. Dev. Cell 20, 364–375 (2011).
Huang, H. et al. AGO3 Slicer activity regulates mitochondria-nuage localization of Armitage and piRNA amplification. J. Cell Biol. 206, 217–230 (2014).
Ku, G. M. et al. Research resource: RNA-Seq reveals unique features of the pancreatic β-cell transcriptome. Mol. Endocrinol. 26, 1783–1792 (2012).
Morán, I. et al. Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab. 16, 435–448 (2012).
Sun, L. et al. Long noncoding RNAs regulate adipogenesis. Proc. Natl Acad. Sci. USA 110, 3387–3392 (2013).
Xu, B. et al. Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity. PLoS ONE 5, e14199 (2010).
Lee, A. H., Scapa, E. F., Cohen, D. E. & Glimcher, L. H. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320, 1492–1496 (2008).
Shao, M. et al. Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling. Nat. Commun. 5, 3528 (2014).
He, C. et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481, 511–515 (2012).
Feng, Y., Yao, Z. & Klionsky, D. J. How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy. Trends Cell Biol. 25, 354–363 (2015).
The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
Odom, D. T. et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 303, 1378–1381 (2004).
Ahmadian, M. et al. PPARγ signaling and metabolism: the good, the bad and the future. Nat. Med. 19, 557–566 (2013).
Gadaleta, R. M., Cariello, M., Sabbà, C. & Moschetta, A. Tissue-specific actions of FXR in metabolism and cancer. Biochim. Biophys. Acta 1851, 30–39 (2015).
Hong, C. & Tontonoz, P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat. Rev. Drug Discov. 13, 433–444 (2014).
Dubuquoy, L. et al. Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360, 1410–1418 (2002).
Puigserver, P. & Rodgers, J. T. Foxa2, a novel transcriptional regulator of insulin sensitivity. Nat. Med. 12, 38–39 (2006).
Lewis, C., Griffiths, B., Santos, C., Pende, M. & Schulze, A. Regulation of the SREBP transcription factors by mTORC1. Biochem. Soc. Trans. 39, 495 (2011).
Dauer, D. J. et al. Stat3 regulates genes common to both wound healing and cancer. Oncogene 24, 3397–3408 (2005).
Scott, R. A. et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat. Genet. 44, 991–1005 (2012).
Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197–206 (2015).
de Rooij, S. R. et al. Glucose tolerance at age 58 and the decline of glucose tolerance in comparison with age 50 in people prenatally exposed to the Dutch famine. Diabetologia 49, 637–643 (2006).
Ravelli, G. P., Stein, Z. A. & Susser, M. W. Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 295, 349–353 (1976).
Roseboom, T. J. et al. Coronary heart disease after prenatal exposure to the Dutch famine, 1944—45. Heart 84, 595–598 (2000).
Rando, O. J. & Simmons, R. A. I'm eating for two: parental dietary effects on offspring metabolism. Cell 161, 93–105 (2015).
Heard, E. & Martienssen, R. A. Transgenerational epigenetic inheritance: myths and mechanisms. Cell 157, 95–109 (2014). This review provides a competent summary of literature and helps the reader to distinguish between real transgenerational or intergenerational effects. It summarizes the mechanisms — identified in plants and various animal model organisms — underlying epigenetic inheritance and reflects on how and to what extent this would be possible in humans.
Treuter, E. & Venteclef, N. Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation. Biochim. Biophys. Acta 1812, 909–918 (2011).
Wadosky, K. M. & Willis, M. S. The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation. Am. J. Physiol. Heart Circ. Physiol. 302, H515–H526 (2012).
Katsura, S., Okumura, T., Ito, R., Sugawara, A. & Yokoyama, A. Identification of posttranslational modifications in peroxisome proliferator-activated receptor γ using mass spectrometry. PPAR Res. 2014, 468925 (2014).
Qiang, L. et al. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell 150, 620–632 (2012).
Ji, S., Park, S. Y., Roth, J., Kim, H. S. & Cho, J. W. O-GlcNAc modification of PPARγ reduces its transcriptional activity. Biochem. Biophys. Res. Commun. 417, 1158–1163 (2012).
Stoffel, M. & Duncan, S. A. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4α regulates expression of genes required for glucose transport and metabolism. Proc. Natl Acad. Sci. USA 94, 13209–13214 (1997).
Yokoyama, A. et al. Multiple post-translational modifications in hepatocyte nuclear factor 4α. Biochem. Biophys. Res. Commun. 410, 749–753 (2011).
Benhamed, F. et al. O-GlcNAcylation links ChREBP and FXR to glucose-sensing. Front. Endocrinol. (Lausanne) 5, 230 (2014).
Eichner, L. J. & Giguère, V. Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks. Mitochondrion 11, 544–552 (2011).
Lu, Q., Hutchins, A. E., Doyle, C. M., Lundblad, J. R. & Kwok, R. P. Acetylation of cAMP-responsive element-binding protein (CREB) by CREB-binding protein enhances CREB-dependent transcription. J. Biol. Chem. 278, 15727–15734 (2003).
Lamarre-Vincent, N. & Hsieh-Wilson, L. C. Dynamic glycosylation of the transcription factor CREB: a potential role in gene regulation. J. Am. Chem. Soc. 125, 6612–6613 (2003).
Eijkelenboom, A. & Burgering, B. M. T. FOXOs: signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 14, 83–97 (2013).
Friedman, J. R. & Kaestner, K. H. The Foxa family of transcription factors in development and metabolism. Cell. Mol. Life Sci. 63, 2317–2328 (2006).
Kohler, S. & Cirillo, L. A. Stable chromatin binding prevents FoxA acetylation, preserving FoxA chromatin remodeling. J. Biol. Chem. 285, 464–472 (2010).
Sutinen, P., Rahkama, V., Rytinki, M. & Palvimo, J. J. Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation. Mol. Endocrinol. 28, 1719–1728 (2014).
Belaguli, N. S., Zhang, M., Brunicardi, F. C. & Berger, D. H. Forkhead box protein A2 (FOXA2) protein stability and activity are regulated by sumoylation. PLoS ONE 7, e48019 (2012).
Park, H.-K. & Ahima, R. S. Leptin signaling. F1000Prime Rep. 6, 73 (2014).
Meier, J. A. & Larner, A. C. Toward a new STATe: the role of STATs in mitochondrial function. Semin. Immunol. 26, 20–28 (2014).
Stark, G. R. & Darnell, J. E. The JAK–STAT pathway at twenty. Immunity 36, 503–514 (2012).
Xu, X., So, J.-S., Park, J.-G. & Lee, A.-H. Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Semin. Liver Dis. 33, 301–311 (2013).
Shao, W. & Espenshade, P. J. Expanding roles for SREBP in metabolism. Cell Metab. 16, 414–419 (2012).
Krycer, J. R., Sharpe, L. J., Luu, W. & Brown, A. J. The Akt–SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol. Metab. 21, 268–276 (2010).
Hirano, Y., Murata, S., Tanaka, K., Shimizu, M. & Sato, R. Sterol regulatory element-binding proteins are negatively regulated through SUMO-1 modification independent of the ubiquitin/26 S proteasome pathway. J. Biol. Chem. 278, 16809–16819 (2003).
Gut, P. & Verdin, E. The nexus of chromatin regulation and intermediary metabolism. Nature 502, 489–498 (2013).
Lu, C. & Thompson, C. B. Metabolic regulation of epigenetics. Cell Metab. 16, 9–17 (2012).
Papanicolaou, K. N., O'Rourke, B. & Foster, D. B. Metabolism leaves its mark on the powerhouse: recent progress in post-translational modifications of lysine in mitochondria. Front. Physiol. 5, 301 (2014). Reviews 153–155 discuss an emerging model in which products of intermediary metabolism influence chromatin accessibility and thus transcription. They summarize the different regulatory levels and interfaces between metabolism and chromatin, providing a detailed summary of the available literature.
Pengelly, A. R., Copur, O., Jackle, H., Herzig, A. & Muller, J. A histone mutant reproduces the phenotype caused by loss of histone-modifying factor Polycomb. Science 339, 698–699 (2013).
Tropberger, P. et al. Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer. Cell 152, 859–872 (2013).
A.L. and J.A.P. are supported by the Max Planck Society, EU-FP7, DFG and an ERC Starting Grant. J.M.P. is supported by the Austrian Academy of Sciences and an Advanced ERC grant. Owing to the broad scope of this Review, the authors could not cite all the original publications and had to rely heavily on citation of more focused review articles. The authors apologize to all authors not cited who have made important contributions.
The authors declare no competing financial interests.
The endocrine system refers to tissues that secrete hormones directly into the circulatory system to be transported to distant target organs.
- Catabolic processes
Processes that break down nutrients to release energy during times of need: for example, during fasting, stress, cold or exercise.
Essential nutrients required in large amounts, such as fat, carbohydrates and proteins.
The oxidative process by which fatty acids are broken down in the mitochondria to generate acetyl-CoA, NADH and FADH2.
- Anabolic processes
Biosynthetic and storage processes favoured during energy excess, to store energy for times of need.
- Afferent neurons
Neurons that carry nerve impulses from peripheral tissues such as muscles and glands towards the central nervous system. They are also known as sensory neurons.
- Efferent neurons
Neurons that carry nerve impulses away from the central nervous system to effector tissues such as muscles and glands. They are also known as motor or effector neurons.
The population of microorganisms that live in and on our body.
- Glucagon-like peptide 1
An endocrine hormone secreted by the gut upon feeding, leading to increased insulin secretion in a glucose-dependent manner.
- Glucose-dependent insulinotropic polypeptide
A hormone secreted by the gut upon feeding that binds to receptors on β-cells, leading to insulin secretion.
A hunger hormone secreted by the stomach that increases appetite by regulating energy usage.
A peptide hormone formed in the pancreas by β-cells. Insulin signalling leads to increased glucose uptake, and glycogen and lipid synthesis.
A peptide hormone formed in the pancreas by α-cells. Glucagon opposes the action of insulin, leading to glycogen breakdown and lipolysis to generate glucose, which is released into the bloodstream.
Hormones secreted by the liver.
- White adipose tissue
A type of adipose tissue that specializes in lipid storage. It is the most important storage tissue and constitutes ideally about 20–25% of the human body. Each white adipocyte usually contains a single large lipid droplet.
Hormones secreted by adipose tissue.
A hormone released by adipocytes, signalling the status of energy stores and regulating appetite by inhibiting hunger.
An adipokine that acts locally and globally to regulate inflammatory pathways, apoptosis and insulin sensitivity.
- Basal metabolic rate
The minimum energy required in a time unit at resting state in a temperature- neutral environment in the post-absorptive state.
- Brown adipose tissue
A type of adipose tissue that specializes in heat production and is especially abundant in newborns and hybernating animals. Brown adipocytes are characterized by multilobular lipid droplets and a high number of mitochondria.
A derivative or by-product of cholesterol metabolism.
A complex of DNA, proteins and RNAs constituting eukaryotic chromosomes.
- Bile acids
Steroid acids produced in the liver from cholesterol. They are secreted into the intestine, where they are important for lipid solubilization and absorption.
- Linoleic acid
A polyunsaturated omega-6 fatty acid belonging to the family of essential fatty acids, which cannot be synthesized by the body itself.
- Pioneer transcription factors
Transcription factors that bind directly to DNA in the context of condensed (silenced) chromatin, with the ability to alter the chromatin environment, making it more or less accessible to other transcription factors.
Glucagon-producing endocrine cells in the pancreas.
Insulin-producing endocrine cells in the pancreas.
- Arcuate nucleus
A group of neurons in the hypothalamus involved in appetite and feeding.
(POMC). A polypeptide hormone precursor that upon cleavage gives rise to several important biologically active peptides, some of which act on distant brain areas involved in feeding behaviour, leading to decreased appetite and increased energy expenditure.
Describes substances that decrease food intake and body weight.
- Agouti-related peptide
(AgRP). A neuropeptide that is co-expressed with neuropeptide Y (NPY) and leads to increased appetite and decreased metabolism and energy expenditure.
Describes substances that increase food intake and body weight.
- Mammalian target of rapamycin complex 1
A protein complex that functions as a sensor for energy and nutrients, and activates protein synthesis.
- Histone code
This hypothesis suggested that distinct histone modifications are specifically recognized by proteins to bring about distinct downstream events.
- Hypoxia inducible factor 1α
A transcription factor that is expressed in response to low oxygen concentrations.
- AMP-activated protein kinase
(AMPK). An enzyme that plays an essential part in cellular energy homeostasis.
- Histone variant
A non-canonical type of histone, with distinct amino acid sequence. Histone variants get incorporated into chromatin only upon eviction of canonical histones.
- Unfolded protein response
An endoplasmic reticulum-mediated stress response. It is activated upon accumulation of unfolded or misfolded proteins in the lumen of the endoplasmic reticulum, leading to translation attenuation and cell cycle arrest.
The selective degradation of mitochondria by autophagy.
The degradation of unnecessary or non-functional cellular components through a specialized organelle called the lysosome. This provides the cell with energy and building blocks during starvation.
- Ketogenic diet
A high-fat, medium-protein, low-carbohydrate diet that forces the body to burn fat rather than carbohydrates.
About this article
Cite this article
Lempradl, A., Pospisilik, J. & Penninger, J. Exploring the emerging complexity in transcriptional regulation of energy homeostasis. Nat Rev Genet 16, 665–681 (2015). https://doi.org/10.1038/nrg3941
This article is cited by
High-fat diet in early life triggers both reversible and persistent epigenetic changes in the medaka fish (Oryzias latipes)
BMC Genomics (2023)
Chemokine C–C motif ligand 2 overexpression drives tissue-specific metabolic responses in the liver and muscle of mice
Scientific Reports (2020)
Nature Communications (2020)
Genome Biology (2019)
Scientific Reports (2018)